ATR vs. EXAS: A Head-to-Head Stock Comparison

Updated on October 6, 2025

Here’s a clear look at ATR and EXAS, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

Symbol	ATR	EXAS
Company Name	AptarGroup, Inc.	Exact Sciences Corporation
Country	United States	United States
GICS Sector	Materials	Health Care
GICS Industry	Containers & Packaging	Biotechnology
Market Capitalization	8.78 billion USD	10.74 billion USD
Exchange	NYSE	NasdaqCM
Listing Date	April 23, 1993	February 1, 2001
Security Type	Common Stock	Common Stock

Historical Performance

This chart compares the performance of ATR and EXAS by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

ATR vs. EXAS: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

Symbol	ATR	EXAS
5-Day Price Return	0.72%	6.26%
13-Week Price Return	-17.28%	6.30%
26-Week Price Return	-10.22%	31.02%
52-Week Price Return	-16.08%	-15.22%
Month-to-Date Return	-0.33%	3.67%
Year-to-Date Return	-15.20%	0.94%
10-Day Avg. Volume	0.37M	2.09M
3-Month Avg. Volume	0.42M	3.03M
3-Month Volatility	24.70%	41.17%
Beta	0.53	1.44

Profitability

Return on Equity (TTM)

ATR

15.30%

Containers & Packaging Industry

Max: 36.99%
Q3: 19.86%
Median: 10.47%
Q1: 6.76%
Min: -0.20%

ATR’s Return on Equity of 15.30% is on par with the norm for the Containers & Packaging industry, indicating its profitability relative to shareholder equity is typical for the sector.

EXAS

-38.37%

Biotechnology Industry

Max: 97.92%
Q3: 11.99%
Median: -19.30%
Q1: -51.29%
Min: -132.03%

EXAS has a negative Return on Equity of -38.37%. This indicates the company is generating a loss for its shareholders, which can be a result of unprofitability or negative shareholder equity and is often a sign of financial distress.

ATR vs. EXAS: A comparison of their Return on Equity (TTM) against their respective Containers & Packaging and Biotechnology industry benchmarks.

Net Profit Margin (TTM)

ATR

10.86%

Containers & Packaging Industry

Max: 10.84%
Q3: 8.25%
Median: 4.91%
Q1: 3.65%
Min: -0.12%

ATR’s Net Profit Margin of 10.86% is exceptionally high, placing it well beyond the typical range for the Containers & Packaging industry. This demonstrates outstanding operational efficiency and a strong competitive advantage in converting revenue into profit.

EXAS

-34.19%

Biotechnology Industry

Max: 73.34%
Q3: 18.98%
Median: -12.96%
Q1: -105.72%
Min: -259.82%

EXAS has a negative Net Profit Margin of -34.19%, indicating the company is operating at a net loss as its expenses exceeded its revenues.

ATR vs. EXAS: A comparison of their Net Profit Margin (TTM) against their respective Containers & Packaging and Biotechnology industry benchmarks.

Operating Profit Margin (TTM)

ATR

14.26%

Containers & Packaging Industry

Max: 22.03%
Q3: 13.09%
Median: 8.06%
Q1: 6.46%
Min: -0.07%

An Operating Profit Margin of 14.26% places ATR in the upper quartile for the Containers & Packaging industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

EXAS

-34.49%

Biotechnology Industry

Max: 78.85%
Q3: 21.90%
Median: -13.30%
Q1: -109.94%
Min: -278.10%

EXAS has a negative Operating Profit Margin of -34.49%. This signifies the company is unprofitable at the operational level, as its core business expenses exceed its revenue.

ATR vs. EXAS: A comparison of their Operating Profit Margin (TTM) against their respective Containers & Packaging and Biotechnology industry benchmarks.

Profitability at a Glance

Symbol	ATR	EXAS
Return on Equity (TTM)	15.30%	-38.37%
Return on Assets (TTM)	8.50%	-16.63%
Net Profit Margin (TTM)	10.86%	-34.19%
Operating Profit Margin (TTM)	14.26%	-34.49%
Gross Profit Margin (TTM)	38.32%	68.19%

Financial Strength

Current Ratio (MRQ)

ATR

1.21

Containers & Packaging Industry

Max: 1.96
Q3: 1.45
Median: 1.33
Q1: 1.09
Min: 0.87

ATR’s Current Ratio of 1.21 aligns with the median group of the Containers & Packaging industry, indicating that its short-term liquidity is in line with its sector peers.

EXAS

2.89

Biotechnology Industry

Max: 16.97
Q3: 8.39
Median: 4.11
Q1: 2.64
Min: 0.74

EXAS’s Current Ratio of 2.89 aligns with the median group of the Biotechnology industry, indicating that its short-term liquidity is in line with its sector peers.

ATR vs. EXAS: A comparison of their Current Ratio (MRQ) against their respective Containers & Packaging and Biotechnology industry benchmarks.

Debt-to-Equity Ratio (MRQ)

ATR

0.40

Containers & Packaging Industry

Max: 4.15
Q3: 2.03
Median: 1.20
Q1: 0.53
Min: 0.23

Falling into the lower quartile for the Containers & Packaging industry, ATR’s Debt-to-Equity Ratio of 0.40 points to a conservative financing strategy. This results in lower financial risk but potentially limits strategic investments compared to more leveraged competitors.

EXAS

0.95

Biotechnology Industry

Max: 1.92
Q3: 0.79
Median: 0.12
Q1: 0.00
Min: 0.00

EXAS’s leverage is in the upper quartile of the Biotechnology industry, with a Debt-to-Equity Ratio of 0.95. While this approach can boost equity growth, it also exposes the company to greater financial vulnerability.

ATR vs. EXAS: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Containers & Packaging and Biotechnology industry benchmarks.

Interest Coverage Ratio (TTM)

ATR

16.67

Containers & Packaging Industry

Max: 13.16
Q3: 8.10
Median: 3.38
Q1: 2.83
Min: 1.06

With an Interest Coverage Ratio of 16.67, ATR demonstrates a superior capacity to service its debt, placing it well above the typical range for the Containers & Packaging industry. This stems from either robust earnings or a conservative debt load.

EXAS

-15.18

Biotechnology Industry

Max: 72.37
Q3: 1.03
Median: -9.59
Q1: -65.05
Min: -163.11

EXAS has a negative Interest Coverage Ratio of -15.18. This indicates that its earnings were insufficient to cover even its operational costs, let alone its interest payments, signaling significant financial distress.

ATR vs. EXAS: A comparison of their Interest Coverage Ratio (TTM) against their respective Containers & Packaging and Biotechnology industry benchmarks.

Financial Strength at a Glance

Symbol	ATR	EXAS
Current Ratio (MRQ)	1.21	2.89
Quick Ratio (MRQ)	0.83	2.32
Debt-to-Equity Ratio (MRQ)	0.40	0.95
Interest Coverage Ratio (TTM)	16.67	-15.18

Growth

Revenue Growth

ATR vs. EXAS: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

ATR vs. EXAS: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

ATR

1.37%

Containers & Packaging Industry

Max: 7.14%
Q3: 4.65%
Median: 3.69%
Q1: 2.00%
Min: 0.00%

ATR’s Dividend Yield of 1.37% is in the lower quartile for the Containers & Packaging industry. This suggests the company’s strategy likely favors retaining earnings for growth over providing a high dividend income.

EXAS

0.00%

Biotechnology Industry

Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

EXAS currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

ATR vs. EXAS: A comparison of their Dividend Yield (TTM) against their respective Containers & Packaging and Biotechnology industry benchmarks.

Dividend Payout Ratio (TTM)

ATR

30.61%

Containers & Packaging Industry

Max: 222.75%
Q3: 132.16%
Median: 65.79%
Q1: 28.53%
Min: 0.00%

ATR’s Dividend Payout Ratio of 30.61% is within the typical range for the Containers & Packaging industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

EXAS

0.00%

Biotechnology Industry

Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

EXAS has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

ATR vs. EXAS: A comparison of their Dividend Payout Ratio (TTM) against their respective Containers & Packaging and Biotechnology industry benchmarks.

Dividend at a Glance

Symbol	ATR	EXAS
Dividend Yield (TTM)	1.37%	0.00%
Dividend Payout Ratio (TTM)	30.61%	0.00%

Valuation

Price-to-Earnings Ratio (TTM)

ATR

22.28

Containers & Packaging Industry

Max: 24.22
Q3: 20.28
Median: 17.07
Q1: 15.06
Min: 7.79

A P/E Ratio of 22.28 places ATR in the upper quartile for the Containers & Packaging industry. This high valuation relative to peers suggests the market holds elevated expectations for the company’s future growth.

EXAS

Biotechnology Industry

Max: 40.44
Q3: 39.37
Median: 22.12
Q1: 15.76
Min: 3.48

P/E Ratio data for EXAS is currently unavailable.

ATR vs. EXAS: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Containers & Packaging and Biotechnology industry benchmarks.

Price-to-Sales Ratio (TTM)

ATR

2.42

Containers & Packaging Industry

Max: 1.99
Q3: 1.17
Median: 0.94
Q1: 0.55
Min: 0.31

With a P/S Ratio of 2.42, ATR trades at a valuation that eclipses even the highest in the Containers & Packaging industry. This implies the market has priced in exceptionally optimistic scenarios for future revenue growth, posing considerable valuation risk.

EXAS

3.63

Biotechnology Industry

Max: 92.67
Q3: 41.36
Median: 8.45
Q1: 4.46
Min: 0.97

In the lower quartile for the Biotechnology industry, EXAS’s P/S Ratio of 3.63 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.

ATR vs. EXAS: A comparison of their Price-to-Sales Ratio (TTM) against their respective Containers & Packaging and Biotechnology industry benchmarks.

Price-to-Book Ratio (MRQ)

ATR

3.83

Containers & Packaging Industry

Max: 4.79
Q3: 3.32
Median: 2.14
Q1: 1.60
Min: 0.89

ATR’s P/B Ratio of 3.83 is in the upper tier for the Containers & Packaging industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.

EXAS

4.06

Biotechnology Industry

Max: 22.72
Q3: 10.68
Median: 4.55
Q1: 2.44
Min: 0.59

EXAS’s P/B Ratio of 4.06 is within the conventional range for the Biotechnology industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

ATR vs. EXAS: A comparison of their Price-to-Book Ratio (MRQ) against their respective Containers & Packaging and Biotechnology industry benchmarks.

Valuation at a Glance

Symbol	ATR	EXAS
Price-to-Earnings Ratio (TTM)	22.28	--
Price-to-Sales Ratio (TTM)	2.42	3.63
Price-to-Book Ratio (MRQ)	3.83	4.06
Price-to-Free Cash Flow Ratio (TTM)	25.54	85.30